|
⚲
|
| Sujal Shah | |
|---|---|
| Firm | |
| Address | 2450 Holcombe Boulevard Suite X Houston, TX 77021 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM ($M) |
|---|---|---|---|---|---|
| Juvia I Coinvest A LP | 021-591812 | Executive Officer | 13.0 M | ||
| Tvardi Therapeutics Inc | 021-403053 | Director | 72.4 M of 75.1 M |
||
| CymaBay Therapeutics Inc | 021-245800 | Executive Officer | 0.3 M of 0.3 M |
||
| CymaBay Therapeutics Inc | 021-204453 | Executive Officer | 30.2 M of 45.0 M |
||